Table 1. UK clinical commissioning group or health authority structures in place relating to liver disease
Named person responsible for liver diseasen (%)Pathway for assessing abnormal LFTsn (%)Pathway for liverdisease more generallyn (%)Processes in place tomonitor adoption and efficacy of pathwayn (%)Monitoring of current local statistics relating to liver diseasen (%)
Englandn = 13520 (15%)49 (36%)36 (27%)21 (16%)45 (33%)
Northern Irelandn = 50 (0%)0 (0%)0 (0%)0 (0%)0 (0%)
Scotlandn = 126 (50%)8 (67%)5 (42%)0 (0%)6 (50%)
Walesn = 76 (86%)7 (100%)5 (71%)1 (14%)4 (57%)
UK totaln = 15932 (20%)64 (40%)46 (29%)22 (14%)55 (35%)

  • LFTs = liver function tests. n = number of commissioning bodies.